Pharmaceutical giant Eli Lilly is readying a PBAC application for tirzepatide, which if successful, would become the first GLP-1 receptor agonist publicly funded for obesity…
The drug semaglutide, commonly known by the brand names Ozempic or Wegovy, was originally developed to help people with type 2 diabetes manage their blood…
Three founders of Eucalyptus, the telehealth corporate known for prescribing semaglutide at scale, have accrued fortunes of $52 million each, according to the Australian Financial…
A systematic review of PCOS treatment shows that doctors and patients agree on one thing: the current approach is not working. The Australian authors evaluated…
For years, Andrew refused to see a GP. If he developed an infection, he’d often rely on his wife’s repeat antibiotic prescriptions. × Welcome to…
Doctors at telehealth corporates have moved to Wegovy and Mounjaro as weight loss treatments ahead of today’s ban on semaglutide compounding. The Federal Government announced…
Novo Nordisk’s subcutaneous weight-loss drug Wegovy will hit Australian shelves this month, two years after it received TGA approval. The once-weekly injectable semaglutide formulation will…
More than a year before the Federal Government announced its compounding ban, the pharmaceutical giant Novo Nordisk was making complaints to AHPRA about pharmacies compounding…
The TGA is banning pharmacists from compounding semaglutide and other GLP-1 receptor agonists, starting 1 October. About 20,000 patients are currently using compounded semaglutide for…
Telehealth corporate Eucalyptus is making headlines for prescribing off-label compounded semaglutide as part of an online weight loss program that costs up to $599 a…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
